These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22674237)

  • 21. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity and reliability of the rapid assessment for adolescent preventive services adolescent health risk assessment.
    Salerno J; Marshall VD; Picken EB
    J Adolesc Health; 2012 Jun; 50(6):595-9. PubMed ID: 22626486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin for severe anorectal pain.
    Hawley PH
    J Pain Symptom Manage; 2002 Jul; 24(1):11-3. PubMed ID: 12183089
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of spasticity in cerebral palsy with botulinum toxin].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis.
    Giovannelli M; Borriello G; Castri P; Prosperini L; Pozzilli C
    Clin Rehabil; 2007 Apr; 21(4):331-7. PubMed ID: 17613573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.
    Charles PD; Gill CE; Taylor HM; Putman MS; Blair CR; Roberts AG; Ayers GD; Konrad PE
    Mov Disord; 2010 Mar; 25(4):466-73. PubMed ID: 20131401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability and validity of the Intercollegiate Stroke Audit Package.
    Gompertz PH; Irwin P; Morris R; Lowe D; Rutledge Z; Rudd AG; Pearson MG
    J Eval Clin Pract; 2001 Feb; 7(1):1-11. PubMed ID: 11240835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S; Turner-Stokes L
    Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical use of botulinum toxin].
    Jost WH
    Nervenarzt; 2008 Jun; 79 Suppl 1():9-14. PubMed ID: 18927958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The place of the botulinum toxin in the management of multiple sclerosis.
    Habek M; Karni A; Balash Y; Gurevich T
    Clin Neurol Neurosurg; 2010 Sep; 112(7):592-6. PubMed ID: 20615606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum treatment for post-stroke spasticity: low dose regime.
    Viriyavejakul A; Vachalathiti R; Poungvarin N
    J Med Assoc Thai; 1998 Jun; 81(6):413-22. PubMed ID: 9676073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
    J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a tool to measure and promote clinical teamwork.
    Guise JM; Deering SH; Kanki BG; Osterweil P; Li H; Mori M; Lowe NK
    Simul Healthc; 2008; 3(4):217-23. PubMed ID: 19088666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin for the management of adult patients with upper motor neuron syndrome.
    Esquenazi A; Mayer NH; Elia AE; Albanese A
    Toxicon; 2009 Oct; 54(5):634-8. PubMed ID: 19470335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European consensus table on the use of botulinum toxin type A in adult spasticity.
    Wissel J; Ward AB; Erztgaard P; Bensmail D; Hecht MJ; Lejeune TM; Schnider P; Altavista MC; Cavazza S; Deltombe T; Duarte E; Geurts AC; Gracies JM; Haboubi NH; Juan FJ; Kasch H; Kätterer C; Kirazli Y; Manganotti P; Parman Y; Paternostro-Sluga T; Petropoulou K; Prempeh R; Rousseaux M; Slawek J; Tieranta N
    J Rehabil Med; 2009 Jan; 41(1):13-25. PubMed ID: 19197564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Guidelines for the treatment of spasticity in adults using Botulinum toxin].
    Aguilar-Barberá M; Bori-Fortuny I; García-Aymerich V; García-Ruiz Espiga PJ; Garreta-Figuera R; Herrera-Galante A; Lanzas-Melendo G; de Miguel-León I; Miquel-Rodríguez F; Pascual-Pascual SI; Póo P; Vivancos-Matellano F
    Rev Neurol; 2004 May 16-31; 38(10):971-8. PubMed ID: 15175981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing spasticity with drugs.
    Simon O; Yelnik AP
    Eur J Phys Rehabil Med; 2010 Sep; 46(3):401-10. PubMed ID: 20927006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin in treating spasticity.
    Das TK; Park DM
    Br J Clin Pract; 1989 Nov; 43(11):401-3. PubMed ID: 2611094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter to the editor: Re: Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
    Dubinsky RM
    Clin Rehabil; 2010 Aug; 24(8):766. PubMed ID: 20702516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.